CLINICAL_TRIALS
trial_result
· 2020-09-04
Clinical Trial Update: A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease [Phase 3]
Summary
Phase 3 dose-ranging trial assessing safety and efficacy of bromfenac ophthalmic solution for dry eye disease completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bausch & Lomb Incorporated | Conditions: Dry Eye Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2020-09-04